Insider filing · TVTX
Jeffrey A Meckler
Director
profile →
Travere Therapeutics, Inc.
TVTX · Healthcare · 74 filings in 24 months
ticker →
Jeffrey A Meckler sold $1.3M of Travere Therapeutics (TVTX)
Executed Sep 10, disclosed Sep 11, 1 day later.
Value, as filed
$1.3M
18,800 sh across 3 lots
Executed
Sep 10
the trade date, as filed
Disclosed
Sep 11
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
JMJeffrey A Meckler (Director) filed 2 Form 4 reports in the trailing twelve months (0 purchases, 2 sales), most often in Travere Therapeutics, Inc. (TVTX). The largest single filing was $1.3M of TVTX (18,800 sh across 3 lots, as filed), executed Sep 10.
The name
TVTXHealthcare · Travere Therapeutics, Inc., a biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Jeffrey A Meckler in TVTX
TVTXSALE
Travere Therapeutics, Inc.
$360K8,000 sh × $45.00
Exec May 4
Filed May 6 · 5:30 PM ET TVTXSALE Travere Therapeutics, Inc. $562K
40,000 sh × $14.06
Exec Sep 30 2024
Filed Sep 30 2024 · 5:30 PM ET